- Report
- July 2024
- 153 Pages
Global
From €3745EUR$4,250USD£3,248GBP
- Report
- November 2022
- 55 Pages
Global
From €1762EUR$2,000USD£1,529GBP
- Report
- April 2024
- 132 Pages
Global
From €837EUR$950USD£726GBP
- Book
- June 2020
- 198 Pages
- Report
- November 2021
- 213 Pages
Global
From €2643EUR$3,000USD£2,293GBP
- Report
- November 2021
- 527 Pages
Global
From €3524EUR$4,000USD£3,057GBP
- Report
- November 2021
- 545 Pages
Global
From €3524EUR$4,000USD£3,057GBP
- Report
- November 2021
- 270 Pages
Global
From €2203EUR$2,500USD£1,911GBP
- Report
- November 2021
- 365 Pages
Global
From €3084EUR$3,500USD£2,675GBP
- Report
- November 2021
- 1184 Pages
Global
From €5287EUR$6,000USD£4,586GBP
- Report
- November 2021
- 233 Pages
Global
From €2203EUR$2,500USD£1,911GBP
- Report
- November 2021
- 1165 Pages
Global
From €5287EUR$6,000USD£4,586GBP
- Book
- September 2021
- 464 Pages
- Book
- April 2020
- 608 Pages
- Book
- March 2020
- 248 Pages
- Book
- December 2019
- 400 Pages
Personalized Medicine is a form of biotechnology that focuses on tailoring medical treatments to the individual needs of a patient. It is based on the idea that each person's genetic makeup, lifestyle, and environment can affect their response to a particular treatment. This approach to medicine has the potential to improve patient outcomes and reduce healthcare costs.
Personalized Medicine utilizes a variety of technologies, such as genomics, proteomics, and metabolomics, to identify and analyze a patient's unique characteristics. This information is then used to develop treatments that are tailored to the individual's needs. Additionally, personalized medicine can be used to identify and monitor diseases, predict drug responses, and develop new treatments.
Some companies in the Personalized Medicine market include 23andMe, Illumina, and Thermo Fisher Scientific. Show Less Read more
